Polypharmacy and Smoking as Potentially Modifiable Risk Factors Associated with Symptom Severity in Men with Lower Urinary Tract Symptoms in Primary Care: Findings from the PriMUS Study

Thomas Purchase; George Trilloe; Haroon Ahmed; Ridhi Agarwal; Alison Bray; Kerenza Hood; Emma Thomas-Jones; Marcus J. Drake; Chris Harding; Adrian Edwards

doi:10.1016/j.euf.2022.01.001

Polypharmacy and Smoking as Potentially Modifiable Risk Factors Associated with Symptom Severity in Men with Lower Urinary Tract Symptoms in Primary Care: Findings from the PriMUS Study

Thomas Purchase^*
, George Trilloe
, Haroon Ahmed
, Ridhi Agarwal
, Alison Bray
, Kerenza Hood
, Emma Thomas-Jones
, Marcus J. Drake
, Chris Harding
, Adrian Edwards

^*Corresponding author for this work

Applied Health Sciences

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	8-10
Number of pages	3
Journal	European Urology Focus
Volume	8
Issue number	1
DOIs	https://doi.org/10.1016/j.euf.2022.01.001
Publication status	Published - 20 Jan 2022

Bibliographical note

Funding Information:
Acknowledgements: This research was part of the wider PriMUS study, which was funded by the National Institute for Health Research (NIHR) Health Technology Assessment Programme (reference: 15-40-05).

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.euf.2022.01.001

https://orca.cardiff.ac.uk/id/eprint/146353/

Cite this

Purchase, T., Trilloe, G., Ahmed, H., Agarwal, R., Bray, A., Hood, K., Thomas-Jones, E., Drake, M. J., Harding, C., & Edwards, A. (2022). Polypharmacy and Smoking as Potentially Modifiable Risk Factors Associated with Symptom Severity in Men with Lower Urinary Tract Symptoms in Primary Care: Findings from the PriMUS Study. European Urology Focus, 8(1), 8-10. https://doi.org/10.1016/j.euf.2022.01.001

@article{a874ac9369b64993992ab76a47aec9c2,

title = "Polypharmacy and Smoking as Potentially Modifiable Risk Factors Associated with Symptom Severity in Men with Lower Urinary Tract Symptoms in Primary Care: Findings from the PriMUS Study",

author = "Thomas Purchase and George Trilloe and Haroon Ahmed and Ridhi Agarwal and Alison Bray and Kerenza Hood and Emma Thomas-Jones and Drake, \{Marcus J.\} and Chris Harding and Adrian Edwards",

note = "Funding Information: Acknowledgements: This research was part of the wider PriMUS study, which was funded by the National Institute for Health Research (NIHR) Health Technology Assessment Programme (reference: 15-40-05).",

year = "2022",

month = jan,

day = "20",

doi = "10.1016/j.euf.2022.01.001",

language = "English",

volume = "8",

pages = "8--10",

journal = "European Urology Focus",

issn = "2405-4569",

publisher = "Elsevier",

number = "1",

}

Purchase, T, Trilloe, G, Ahmed, H, Agarwal, R, Bray, A, Hood, K, Thomas-Jones, E, Drake, MJ, Harding, C & Edwards, A 2022, 'Polypharmacy and Smoking as Potentially Modifiable Risk Factors Associated with Symptom Severity in Men with Lower Urinary Tract Symptoms in Primary Care: Findings from the PriMUS Study', European Urology Focus, vol. 8, no. 1, pp. 8-10. https://doi.org/10.1016/j.euf.2022.01.001

Polypharmacy and Smoking as Potentially Modifiable Risk Factors Associated with Symptom Severity in Men with Lower Urinary Tract Symptoms in Primary Care: Findings from the PriMUS Study. / Purchase, Thomas; Trilloe, George; Ahmed, Haroon et al.
In: European Urology Focus, Vol. 8, No. 1, 20.01.2022, p. 8-10.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Polypharmacy and Smoking as Potentially Modifiable Risk Factors Associated with Symptom Severity in Men with Lower Urinary Tract Symptoms in Primary Care

T2 - Findings from the PriMUS Study

AU - Purchase, Thomas

AU - Trilloe, George

AU - Ahmed, Haroon

AU - Agarwal, Ridhi

AU - Bray, Alison

AU - Hood, Kerenza

AU - Thomas-Jones, Emma

AU - Drake, Marcus J.

AU - Harding, Chris

AU - Edwards, Adrian

N1 - Funding Information: Acknowledgements: This research was part of the wider PriMUS study, which was funded by the National Institute for Health Research (NIHR) Health Technology Assessment Programme (reference: 15-40-05).

PY - 2022/1/20

Y1 - 2022/1/20

UR - https://www.scopus.com/pages/publications/85123084714

U2 - 10.1016/j.euf.2022.01.001

DO - 10.1016/j.euf.2022.01.001

M3 - Article

C2 - 35065904

AN - SCOPUS:85123084714

SN - 2405-4569

VL - 8

SP - 8

EP - 10

JO - European Urology Focus

JF - European Urology Focus

IS - 1

ER -